- For Researchers
- For Biospecimen Contributors
- For Patients
- Human Biospecimens
May 25, 2016
Do you know someone that has been impacted by cancer? The answer is almost always going to be yes. This year alone, an estimated 1.6 million new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease. Cancer research is helping to transform and save lives, and […]
May 18, 2016
By Christopher Ianelli, MD, PhD, CEO, iSpecimen The HITECH Act of 2009 put into place a number of federally-funded incentives to encourage the adoption of EMRs. The benefits of EMRs are clear – fewer medical errors, more coordinated care, and ultimately, lower costs. However, the time and money associated with implementing them has proven to […]
May 10, 2016
With the widespread adoption of electronic medical records (EMRs) and overall digitization of healthcare upon us, it is no longer just primary care physicians who benefit from the increased data wellspring in medicine. An influx of patient information, along with other advances in technology and the expansion of precision medicine, is allowing for a new […]
May 4, 2016
Welcome to the second installment of “Specimen Spotlight” – a monthly series in which we examine a particularly interesting specimen order completed during the previous four weeks. The demand for cancer biospecimens, particularly with specific inclusion and exclusion criteria, continues to soar. Cancer research is taking off stronger and faster than ever before, with ambitious […]
Create a login in seconds, for free, with no obligation. Gain immediate access to our real-time sample inventory today.
Already signed up? Login to search our updated inventory.